Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 13, 2015

Primary Completion Date

May 9, 2016

Study Completion Date

May 9, 2016

Conditions
Seizures
Interventions
DRUG

Cannabidiol Oral Solution

An oral solution containing pharmaceutical grade cannabidiol (nonplant-based).

Trial Locations (10)

19104

Children's Hospital of Philadelphia, Philadelphia

32504

Child Neurology Center - NW F, Pensacola

33155

Miami Children's Hospital, Miami

38103

Le Bonheur Children's Hospital, Memphis

60637

University of Chicago Medical Center, Chicago

79219

Texas Scottish Rite Hospital for Children, Dallas

89104

Clinical Research Center of Nevada LLC, Las Vegas

94143

University of California San Francisco Medical Center, San Francisco

97239

Oregon Health Services University, Portland

98403

Mary Bridge Children's Hospital, Tacoma

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT02324673 - Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | Biotech Hunter | Biotech Hunter